215 related articles for article (PubMed ID: 37378783)
41. Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19.
Kar P; Saleh-E-In MM; Jaishee N; Anandraj A; Kormuth E; Vellingiri B; Angione C; Rahman PKSM; Pillay S; Sen A; Naidoo D; Roy A; Choi YE
J Cell Biochem; 2022 May; 123(5):964-986. PubMed ID: 35342986
[TBL] [Abstract][Full Text] [Related]
42. Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR.
Shakeeb N; Varkey P; Hynse A; Mandlecha A
Inflammopharmacology; 2022 Jun; 30(3):883-894. PubMed ID: 35320494
[TBL] [Abstract][Full Text] [Related]
43. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
44. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.
Amere Subbarao S
Inflammopharmacology; 2021 Apr; 29(2):343-366. PubMed ID: 33723711
[TBL] [Abstract][Full Text] [Related]
45. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns.
Chatterton DE; Nguyen DN; Bering SB; Sangild PT
Int J Biochem Cell Biol; 2013 Aug; 45(8):1730-47. PubMed ID: 23660296
[TBL] [Abstract][Full Text] [Related]
46. Statins in heart failure--With preserved and reduced ejection fraction. An update.
Tousoulis D; Oikonomou E; Siasos G; Stefanadis C
Pharmacol Ther; 2014 Jan; 141(1):79-91. PubMed ID: 24022031
[TBL] [Abstract][Full Text] [Related]
47. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
48. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
[TBL] [Abstract][Full Text] [Related]
49. An open label trial of anakinra to prevent respiratory failure in COVID-19.
Kyriazopoulou E; Panagopoulos P; Metallidis S; Dalekos GN; Poulakou G; Gatselis N; Karakike E; Saridaki M; Loli G; Stefos A; Prasianaki D; Georgiadou S; Tsachouridou O; Petrakis V; Tsiakos K; Kosmidou M; Lygoura V; Dareioti M; Milionis H; Papanikolaou IC; Akinosoglou K; Myrodia DM; Gravvani A; Stamou A; Gkavogianni T; Katrini K; Marantos T; Trontzas IP; Syrigos K; Chatzis L; Chatzis S; Vechlidis N; Avgoustou C; Chalvatzis S; Kyprianou M; van der Meer JW; Eugen-Olsen J; Netea MG; Giamarellos-Bourboulis EJ
Elife; 2021 Mar; 10():. PubMed ID: 33682678
[TBL] [Abstract][Full Text] [Related]
50. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways.
Futosi K; Fodor S; Mócsai A
Int Immunopharmacol; 2013 Dec; 17(4):1185-97. PubMed ID: 24263067
[TBL] [Abstract][Full Text] [Related]
51. Blocking TNF signaling may save lives in COVID-19 infection.
Ablamunits V; Lepsy C
Mol Biol Rep; 2022 Mar; 49(3):2303-2309. PubMed ID: 35076845
[TBL] [Abstract][Full Text] [Related]
52. Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2.
Antar SA; Saleh MA; Al-Karmalawy AA
Life Sci; 2022 Nov; 309():121048. PubMed ID: 36209833
[TBL] [Abstract][Full Text] [Related]
53. Chebulanin exerts its anti-inflammatory and anti-arthritic effects via inhibiting NF-κB and MAPK activation in collagen-induced arthritis mice.
Liu F; Liu Y; Zhan S; Lv J; Sun F; Weng B; Liu S; Xia P
Int Immunopharmacol; 2020 Nov; 88():106823. PubMed ID: 32795901
[TBL] [Abstract][Full Text] [Related]
54. The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases.
Efferth T; Oesch F
Med Res Rev; 2021 Nov; 41(6):3023-3061. PubMed ID: 34288018
[TBL] [Abstract][Full Text] [Related]
55. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
Ma Q; Pan W; Li R; Liu B; Li C; Xie Y; Wang Z; Zhao J; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Yang Z
Pharmacol Res; 2020 Aug; 158():104850. PubMed ID: 32360580
[TBL] [Abstract][Full Text] [Related]
56. Neutrophil cell surface receptors and their intracellular signal transduction pathways.
Futosi K; Fodor S; Mócsai A
Int Immunopharmacol; 2013 Nov; 17(3):638-50. PubMed ID: 23994464
[TBL] [Abstract][Full Text] [Related]
57. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
Quirch M; Lee J; Rehman S
J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
[TBL] [Abstract][Full Text] [Related]
58. An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19).
Elahi R; Karami P; Heidary AH; Esmaeilzadeh A
Int Immunopharmacol; 2022 Apr; 105():108536. PubMed ID: 35074571
[TBL] [Abstract][Full Text] [Related]
59. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
Norooznezhad AH; Mansouri K
Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
[TBL] [Abstract][Full Text] [Related]
60. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
Bifulco M; Gazzerro P
Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
